CH698144B1 - Analogue de la vitamine D3 - Google Patents

Analogue de la vitamine D3 Download PDF

Info

Publication number
CH698144B1
CH698144B1 CH01553/04A CH15532004A CH698144B1 CH 698144 B1 CH698144 B1 CH 698144B1 CH 01553/04 A CH01553/04 A CH 01553/04A CH 15532004 A CH15532004 A CH 15532004A CH 698144 B1 CH698144 B1 CH 698144B1
Authority
CH
Switzerland
Prior art keywords
compound
alpha
prostate
cells
bph
Prior art date
Application number
CH01553/04A
Other languages
English (en)
French (fr)
Inventor
Luciano Adorini
Enrico Colli
Original Assignee
Bioxell Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0322395A external-priority patent/GB0322395D0/en
Priority claimed from GB0325598A external-priority patent/GB2407499B/en
Priority claimed from GB0416876A external-priority patent/GB0416876D0/en
Application filed by Bioxell Spa filed Critical Bioxell Spa
Publication of CH698144B1 publication Critical patent/CH698144B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
CH01553/04A 2003-09-24 2004-09-22 Analogue de la vitamine D3 CH698144B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0322395A GB0322395D0 (en) 2003-09-24 2003-09-24 Methods for treating bladder dysfunction and related compounds and compositions
GB0325598A GB2407499B (en) 2003-11-03 2003-11-03 Vitamin D3 analogue for use in the treatment of BPH
GB0416876A GB0416876D0 (en) 2004-07-29 2004-07-29 Compound and use in treatment

Publications (1)

Publication Number Publication Date
CH698144B1 true CH698144B1 (fr) 2009-05-29

Family

ID=34229055

Family Applications (1)

Application Number Title Priority Date Filing Date
CH01553/04A CH698144B1 (fr) 2003-09-24 2004-09-22 Analogue de la vitamine D3

Country Status (12)

Country Link
EP (1) EP1673096A1 (zh)
JP (2) JP2007506699A (zh)
CN (1) CN100488511C (zh)
BE (1) BE1016292A3 (zh)
BR (1) BRPI0404050A (zh)
CH (1) CH698144B1 (zh)
EA (1) EA010240B1 (zh)
FR (1) FR2859910B1 (zh)
HK (1) HK1085373A1 (zh)
NL (1) NL1027109C2 (zh)
NZ (1) NZ535531A (zh)
WO (1) WO2005027923A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006038611A1 (ja) * 2004-10-05 2006-04-13 Kissei Pharmaceutical Co., Ltd. 下部尿路閉塞疾患に伴う蓄尿障害の予防及び／又は治療剤
JPWO2006038619A1 (ja) * 2004-10-06 2008-05-15 キッセイ薬品工業株式会社 前立腺肥大症に対する手術療法への移行予防用医薬組成物
US20100009949A1 (en) * 2006-03-24 2010-01-14 Bioxell S.P.A. Novel method
US8221803B1 (en) 2007-06-25 2012-07-17 OncoNatural Solutions, Inc. Composition for prostate health
US20120164240A1 (en) 2010-12-22 2012-06-28 Audino David Lawrence Enriched a. blitoides compositions and uses thereof
US20170049834A1 (en) * 2015-08-18 2017-02-23 Golden Biotechnology Corporation Benign prostatic hyperplasia add-on therapy
FR3063906A1 (fr) * 2017-03-20 2018-09-21 Pierre Fabre Medicament Utilisation de l'oleoresine de copaifera dans les pathologies de la prostate

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763429A (en) * 1993-09-10 1998-06-09 Bone Care International, Inc. Method of treating prostatic diseases using active vitamin D analogues
TW403735B (en) * 1995-11-22 2000-09-01 Hoffmann La Roche 25-hydroxy-16-ene-26, 27-bishomo-cholecalciferol
SG70009A1 (en) * 1996-05-23 2000-01-25 Hoffmann La Roche Vitamin d3 analogs
EP0981523B1 (en) * 1997-05-16 2005-12-07 Woman & Infants Hospital Cyclic ether vitamin d3 compounds, 1alpha (oh) 3-epi-vitamin d3 compounds and uses thereof
US5872113A (en) * 1997-05-16 1999-02-16 Syntex (U.S.A.) Inc. Fluorinated vitamin D3 analogs
US6255501B1 (en) * 1999-04-26 2001-07-03 Hoffman-La Roche Inc. Process for preparing antiosteoporotic agents
WO2003034961A1 (en) * 2001-10-23 2003-05-01 Euro-Celtique, S.A. Terazosin transdermal device and methods
HUP0501186A2 (en) * 2001-12-03 2006-05-29 Novacea Pharmaceutical compositions comprising active vitamin d compounds

Also Published As

Publication number Publication date
EA010240B1 (ru) 2008-06-30
WO2005027923A1 (en) 2005-03-31
NZ535531A (en) 2006-03-31
JP2009035559A (ja) 2009-02-19
EA200401100A1 (ru) 2005-04-28
NL1027109A1 (nl) 2005-03-29
HK1085373A1 (en) 2006-08-25
NL1027109C2 (nl) 2005-05-03
FR2859910B1 (fr) 2006-04-28
EP1673096A1 (en) 2006-06-28
JP2007506699A (ja) 2007-03-22
BRPI0404050A (pt) 2005-06-14
CN100488511C (zh) 2009-05-20
CN1615891A (zh) 2005-05-18
BE1016292A3 (nl) 2006-07-04
FR2859910A1 (fr) 2005-03-25

Similar Documents

Publication Publication Date Title
Wang et al. Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK
TWI339118B (en) Treating muscle wasting with selective androgen receptor modulators
FR2803516A1 (fr) Formulation injectable de fulvestrant
EP2564854B1 (fr) Traitement de l'insuffisance cardiaque chez les animaux mammiferes non humains par un antagoniste de l'aldostérone
JPH11507022A (ja) ５α−リダクターゼ活性を阻害する方法および組成物
US20080207769A1 (en) Method for treating benign prostatic hyperplasia
JP2021525802A (ja) Ｐｉ３ｋに関連する疾患または障害に対する併用療法
FR3061658A1 (fr) Composition pharmaceutique comprenant en tant que principe actif une combinaison de d-limoneme, de lupeol et du cinnamaldehyde et/ou du methylhydroxychalcone polymere et/ou du beta-sitosterol et/ou de
JP2009035559A (ja) 良性前立腺肥大の治療のためのビタミンｄ３アナログの使用
KR20190018486A (ko) 암의 예방 및/또는 치료를 위한 화합물, 조성물 및 방법
AU2008323199B2 (en) C-19 steroids for therapeutic uses
JP2021169508A (ja) 高濃度配合物
KR101057485B1 (ko) 1,2-디티올티온 유도체를 함유하는 엘엑스알-알파 과다발현으로 인한 질병의 예방 및 치료용 약학 조성물
CZ200377A3 (cs) 7-Hydroxyepiandrosteron s neuroprotektivním účinkem
JP2021519799A (ja) 物質離脱障害を治療するためのｇａｂａ−ａアンタゴニスト
KR100576157B1 (ko) 비만 예방 또는 치료용 약학 조성물
JPWO2017209270A1 (ja) ２５−ヒドロキシコレステロール又はその類縁体コレステロールを有効成分として含有してなる、活性化されたｔ細胞及び／又はｂ細胞に選択的な細胞死誘導剤又は細胞死促進剤
JP2024521740A (ja) ２型ヨードチロニンデヨージナーゼ（ｄ２）阻害剤の新しい治療的使用
KR101712747B1 (ko) 유파틸린을 유효성분으로 포함하는 피부질환 예방 또는 치료용 조성물
FR3063644A1 (fr) Prevention des effets adverses des statines a l'aide d'un inhibiteur specifique de la production de ros d'origine mitochondriale
GB2407499A (en) Compound and use in treatment
JP2020516696A (ja) 多嚢胞性卵巣症候群を治療するためのイソフムロン及びその誘導体の使用
First-Testosterone et al. Drug Description
EP0927027A1 (fr) Utilisation d'antagonistes 5-ht 4? dans la regulation de la secretion de corticosteroides

Legal Events

Date Code Title Description
PL Patent ceased